Intrathecal IgG Synthesis: A Resistant and Valuable Target for Future Multiple Sclerosis Treatments

Intrathecal IgG synthesis is a key biological feature of multiple sclerosis (MS). When acquired early, it persists over time. A growing body of evidence suggests that intrathecal Ig-secreting cells may be pathogenic either by a direct action of toxic IgG or by locally secreting bystander toxic produ...

Descripción completa

Detalles Bibliográficos
Autor principal: Bonnan, Mickael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4306411/
https://www.ncbi.nlm.nih.gov/pubmed/25653878
http://dx.doi.org/10.1155/2015/296184

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4306411/
https://www.ncbi.nlm.nih.gov/pubmed/25653878
http://dx.doi.org/10.1155/2015/296184

Ejemplares similares